Aceragen | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Abbott USD 1.78B 252M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Cipla INR 15.04B 4.12B 2025-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6113000 11.89M 2024-12
CSL USD 2.54B 1.34B 2024-12
Dynavax Technologies USD -97875000 105.5M 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Grifols 66.98M 19.92M 2024-06
Merck USD 5.22B 114M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
X T L Biopharmaceuticals -385000 168K 2024-12



Aceragen L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.